ANI Pharmaceuticals Inc (ANIP)
Total asset turnover
| Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | ||
|---|---|---|---|---|---|---|
| Revenue | US$ in thousands | 614,376 | 486,816 | 316,385 | 216,136 | 208,475 |
| Total assets | US$ in thousands | 1,283,700 | 904,422 | 760,087 | 771,598 | 461,190 |
| Total asset turnover | 0.48 | 0.54 | 0.42 | 0.28 | 0.45 |
December 31, 2024 calculation
Total asset turnover = Revenue ÷ Total assets
= $614,376K ÷ $1,283,700K
= 0.48
Total asset turnover measures the efficiency with which a company generates revenue from its total assets. In the case of ANI Pharmaceuticals Inc, the total asset turnover has fluctuated over the past five years.
As of December 31, 2020, the total asset turnover was 0.45, indicating that the company generated $0.45 in revenue for every dollar of total assets. However, by December 31, 2021, this ratio decreased to 0.28, suggesting a decline in the company's ability to utilize its assets to generate revenue efficiently.
Subsequently, there was an improvement in total asset turnover, reaching 0.42 by December 31, 2022. This uptick indicates a better utilization of assets to generate revenue compared to the previous year. The trend continued positively as of December 31, 2023, with a total asset turnover of 0.54, indicating that the company was generating more revenue relative to its total assets.
However, by December 31, 2024, the total asset turnover ratio decreased slightly to 0.48, suggesting a small dip in asset efficiency compared to the previous year. Overall, ANI Pharmaceuticals Inc has shown fluctuations in its total asset turnover over the years, with varying levels of asset efficiency in generating revenue during the period under consideration.
Peer comparison
Dec 31, 2024